← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2014Last known activity
Oct 27, 2021
Acquired by Ipsen on Apr 18, 2019
Timeline
2010s
- Jan 1, 2011
Clementia Pharmaceuticals Inc.— Founded
- Apr 18, 2019
Ipsen— Acquired By
Drugs by trial phase (3 distinct, 10 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05039515Lead sponsorPhase 2Oct 27, 2021
- NCT04829773Lead sponsorPhase 1Jan 3, 2019
- NCT04762355Lead sponsorPhase 1Aug 30, 2018
- NCT03442985Lead sponsorPhase 2Apr 20, 2018
- NCT03312634Lead sponsorPhase 3Nov 28, 2017
- NCT02979769Lead sponsorPhase 2Nov 1, 2016
- NCT02521792Lead sponsorPhase 2Jan 1, 2016
- NCT04829786Lead sponsorPhase 1Sep 1, 2015
- NCT02279095Lead sponsorPhase 2Oct 1, 2014
- NCT02190747Lead sponsorPhase 2Jul 1, 2014
Details
- Founded
- Montreal, CA Jan 1, 2011
- Last known activity
- Oct 27, 2021